Sarsys AB (NGM:SARS)
Sweden · Delayed Price · Currency is SEK 0.5600
+0.0200 (3.70%)
At close: Sep 24, 2026
Sarsys AB Revenue
Sarsys AB had revenue of 20.06M SEK in the quarter ending June 30, 2026, with 110.95% growth. This brings the company's revenue in the last twelve months to 53.75M, up 25.73% year-over-year. In the year 2025, Sarsys AB had annual revenue of 42.36M with 3.20% growth.
Revenue (ttm)
53.75M
Revenue Growth
+25.73%
P/S Ratio
0.53
Revenue / Employee
2.69M
Employees
20
Market Cap
28.47M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.36M | 1.31M | 3.20% |
| Dec 31, 2024 | 41.05M | -2.33M | -5.38% |
| Dec 31, 2023 | 43.38M | 8.10M | 22.96% |
| Dec 31, 2022 | 35.28M | 2.07M | 6.24% |
| Dec 31, 2021 | 33.21M | -31.72M | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thinc Collective AB | 321.00M |
| Jumpgate AB | 42.69M |
| Diadrom Holding AB | 37.88M |
| ODI Pharma AB | 32.92M |
| GreenMerc AB | 17.24M |
| LightAir AB | 14.43M |
| Kvix AB | 13.01M |
| Nattaro Labs AB | 6.54M |
Sarsys AB News
- 4 weeks ago - Sarsys AB Quarterly report: H1 2026 - Filings
- 7 months ago - Sarsys AB Annual report: Q4 2025 - Filings
- 7 months ago - Sarsys AB Quarterly report: Q4 2025 - Filings